drugset / Trial / NCT02066844

Navigator vs Standard Needle Injection for Hip

NCT02066844

Phase 2 Completed 40 enrolled Cartiva, Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this randomized, parallel-group, single-blinded, single center, Phase II study is to collect data to compare the comfort and patient satisfaction of a hip injection delivered via the Navigator compared to a standard needle injection. In addition, delivery preparation will be compared between a Navigator injection and a standard hip injection. The data collected from this pilot study will serve as the basis to design a larger multi-center study.

Timeline

Start
2014-02
Primary completion
2014-08
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Background Betamethasone Other / unclassified 2 ml
Background Lidocaine Other / unclassified 5 ml

Indications